Pancreatic ductal adenocarcinoma (PDAC) is recognized as one of the most lethal cancers, with an estimated five-year survival rate of approximately...

FRIDAY, Nov. 15, 2024 -- Newly diagnosed pancreatic cancer patients receiving palliative care (PC) consultations have an increased prevalence of...

FRIDAY, Nov. 15, 2024 -- Newly diagnosed pancreatic cancer patients receiving palliative care (PC) consultations have an increased prevalence of...

Innovative urinary miRNA profiling shows potential for early pancreatic cancer detection, with high accuracy and sensitivity, transforming screening...

Using a gene signature technique to tailor chemotherapy for patients with early triple-negative breast cancer shows promise as a way to improve...

Adding immunotherapy to neoadjuvant chemoradiation can improve survival and enable surgery in esophageal cancer, reveals research results published...

Researchers from The University of Texas MD Anderson Cancer Centre, USA, demonstrated that anti-PD-L1 immunotherapy in combination with...

The medicine - branded Lenvima - stops cancer cells from multiplying, slowing the disease's progression.

Pancreatic incidentalomas can be detected in their early stage using a less invasive method to provide proper prognosis and treatment for patients.

– Technique offers new hope for increased survival in patients with brain tumors. University of California – San Francisco What’s new An...